FDA 블랙박스 경고: SERTRALINE HYDROCHLORIDE
FDA 블랙박스 경고 — SERTRALINE HYDROCHLORIDE (Sertraline Hydrochloride)
2026-03-11
블랙박스 경고
Sertraline Hydrochloride (SERTRALINE HYDROCHLORIDE) — Legacy Pharmaceutical Packaging, LLC
BOXED WARNING WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [See WARNINGS AND PRECAUTIONS (5.1)]. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING. Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients (5.1) Closely monitor for clinical worsening and emergence of suicidal thoughts and behaviors (5.1)
약물 상호작용
7 DRUG INTERACTIONS Protein-bound drugs: Monitor for adverse reactions and reduce dosage of sertraline or other protein-bound drugs (e.g., warfarin) as warranted. (7.1, 12.3) CYP2D6 substrates: Reduce dosage of drugs metabolized by CYP2D6 ( 7.1 , 12.3 ) 7.1 Clinically Significant Drug Interactions Table 5 includes clinically significant drug interactions with sertraline [See Clinical Pharmacology (12.3) ]. Table 5: Clinically-Significant Drug Interactions with Sertraline Monoamine Oxidase Inhibi
주의사항
이 정보는 FDA 공공 데이터를 기반으로 하며, 의사/약사의 전문적 판단을 대체하지 않습니다.
복용 중인 약이 해당되는지 확인하세요
상호작용 체크하러 가기이 정보는 공식 안전 정보를 기반으로 하며, 의사/약사의 전문적 판단을 대체하지 않습니다.